News

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
Oncolytics Biotech reveals promising survival data for pelareorep, an innovative immunotherapy, showing significant benefits ...
Detailed price information for Citius Pharmaceuticals Inc (CTXR-Q) from The Globe and Mail including charting and trades.
USA News Group News Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that looming cuts ...
Cancer immunotherapy has transformed the treatment landscape by helping the immune system recognize and attack tumors. At the ...
Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a leading clinical-stage company specializing in immunotherapy for oncology, received a formal letter (the ...
Cancer cells and tumors do not exist in a vacuum. Far from the isolation and self-sufficiency of the fictional Wakanda, ...
Cancer cells and tumors do not exist in a vacuum. Far from the isolation and self-sufficiency of the fictional Wakanda, ...
Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors ...
A diagnosis of pancreatic cancer is devastating. More than 67,000 people in the U.S. are diagnosed with this deadly cancer each year, and more than 50,000 die. Early detection and ...
A new test called PAC-MANN is designed to detect signs of pancreatic cancer in blood. It's still in development, but the hope is that it will help catch the deadly cancer early.